Sort   by:  
 Page size 
0
Resistance to proteasome inhibitors (PIs) is a ubiquitous clinical concern in multiple myeloma. We proposed that signaling-level responses after PI would reveal new means to enhance efficacy. Unbiased phosphoproteomics after the PI carfilzomib surprisingly demonstrated the most prominent phosphoryl...
ORGANISM(S): Homo Sapiens (human) 
2020-02-21 | PXD012172 | Pride
0
Hepatocellular carcinoma (HCC) is the leading cause of cancer-related deaths worldwide, reflecting the need for a better understanding of hepatocarcinogenesis. In this study, we examined the genome-wide expression profiles of both miRNAs and mRNAs from paired tumor and adjacent non-tumor tissues from ...
ORGANISM(S): Homo sapiens 
1K
...tter understand the link between low-frequency and rare genetic changes, and human disease caused by harmful changes to the proteins the body makes. Although many hundre...
...efore. Please note that a publication moratorium is in place to protect the first publication rights of UK10K sample custodians and data generators. This moratorium will expire on 02 July 201...
1K
Organisation EGAO00000000902
1K
Organisation EGAO00000000903
0

MESA
The Multi-Ethnic Study of Atherosclerosis (MESA) is a study of the characteristi...
...lar disease or progression of the subclinical disease. MESA researchers study a diverse, population-based sample of 6,814 asymptomatic men and women aged 45-84. Thirty-eight percent of the recruited particip...

0

In this paper (Gibbs et al., 2010, PMID: 20485568) we ...
...studied the cerebellum, frontal cortex, temporal cortex and pons regions of 150 individuals (600 tissue samples). In each tissue we assessed 27,57...

1K
Organisation EGAO00000000099
0

The Family Heart Study (FamHS) was funded by the National Heart, Lung, and Blood Institute (NHLBI). It was begun in 1992 with the ascertainment of 1,200 families, half randomly sampled, and half selected because of an excess of coronary heart disease (CHD) or risk factor abnormalities as compared ...

1K
The mandate of the Genome Sciences Centre at BCCA is to advance knowledge about cancer and other diseases, to improve human health through disease prevention, diagnosis and therapeutic approaches, and to realize the social and economical benefits of genomics and informatics research
Sort   by:  
 Page size